Zhou et al. [13] did report significantly lower BDNF levels in PSD patients at a later stage in the evolution of their stroke (three to six months), but this is contradicted by Yang et al.’s finding that the early significant difference was no longer apparent by day seven post-stroke [12]. This evidence concerns the gene BDNF and stroke disorder.